FEV1 is a major prognostic factor in diverse Heart Failure populations: findings from a Global Heart Failure registry [0.03%]
FEV1是不同心脏衰竭人群中主要的预后因素：来自全球心脏衰竭注册表的研究发现
MyLinh Duong,Shofiqul Islam,Philip Joseph et al.
MyLinh Duong et al.
Aims: Pulmonary abnormalities are commonly reported in heart failure (HF) and may have prognostic implication. Current evidence is limited to high-income countries. We examined the relationship between forced expiratory v...
One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain [0.03%]
西班牙VERCETTLE研究：维卡格鲁阿格片在中国的多中心真实世界研究一年随访结果
Alberto Esteban-Fernández,Beatriz Calvo-Bernal,Raquel López-Vilella et al.
Alberto Esteban-Fernández et al.
Aims: To evaluate the effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction (HFrEF) following recent decompensation in routine clinical practice in Spain. ...
Cardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction [0.03%]
基于心脏磁共振的左心房室耦合指数可预测射血分数降低型心衰患者的预后
Marco Guglielmo,Damiano Fedele,Luca Bergamaschi et al.
Marco Guglielmo et al.
Background: The left atrioventricular coupling index (LACI) has emerged as a potential prognostic marker in several clinical settings. This study evaluated the prognostic value of cardiac magnetic resonance (CMR)-derived ...
Characterisation of Incident Heart Failure after Ischaemic Stroke/Transient Ischaemic Attack: A UK Biobank Study [0.03%]
英国生物银行研究中缺血性卒中/短暂性脑缺血发作后发生的初始心力衰竭的特征分析
Rahul G Muthalaly,Nitesh Nerlekar,Sean Tan et al.
Rahul G Muthalaly et al.
Aims: To define incident heart failure (HF) risk in ischaemic stroke/TIA survivors. The secondary aims were to define the association of HF with all-cause mortality in stroke survivors and to describe their cardiac magnet...
Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial [0.03%]
基于TRISCEND II试验的TTVR-EVOQUE系统在重度三尖瓣反流患者中的成本效益分析
Apolline Grangeon,Martin Connock,Peter Auguste et al.
Apolline Grangeon et al.
Aims: The Evoque™ transcatheter tricuspid valve replacement (TTVR) system demonstrated superiority over optimal medical treatment (OMT) in the TRISCEND II trial. We aimed to evaluate the cost-effectiveness of TTVR in pat...
Stress cardiomyopathy in vascular Ehlers-Danlos syndrome: first case report and proposed mechanisms [0.03%]
血管Ehlers-Danlos综合征应激性心肌病首例报道及可能机制分析
Xiaoru Che,Zhenzhen Wang,Xiaohua Tang et al.
Xiaoru Che et al.
Apical Myocardial Fibrosis Burden Identifies a High-Risk Phenotype and Predicts Cardiac Mortality After LVAD Implantation [0.03%]
心室辅助装置植入后出现的心尖部心肌纤维化负荷识别高危表型及预测心脏死亡事件
İbrahim Demir,Bilge Ecemiş,Ayşe Zorba et al.
İbrahim Demir et al.
Aim: Advanced heart failure is characterized by progressive myocardial remodeling, with fibrosis representing a final common pathway of chronic injury. We investigated whether quantitatively assessed apical myocardial fib...
Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: Design and rationale of the Reduce-MFA DZHK25 trial [0.03%]
经导管主动脉瓣置换术后抗纤维化治疗对心肌纤维化消退的影响：Reduce-MFA DZHK25试验的设计与原理
Miriam Puls,Elisabeth M Zeisberg,Marius Placzek et al.
Miriam Puls et al.
Aims: Myocardial fibrosis (MF) represents a key player in transition to heart failure in aortic stenosis (AS), and AS patients with high baseline MF are at increased risk to die within 12 months after TAVI. Therefore, the...
Interaction of Secondary Ventricular Tricuspid Regurgitation with RV in HFREF: An Invasive Pressure-Volume Loop Study [0.03%]
二次三尖瓣反流对HFREF患者右心室相互作用的影响：压力容积环研究
Alexander Schmeisser,Thomas Rauwolf,Thomas Groscheck et al.
Alexander Schmeisser et al.
Introduction: Heart failure with reduced ejection fraction (HFREF) accompanied by moderate or severe ventricular tricuspid-valve leaflet regurgitation (vTR2/3) is prognostically unfavourable, however, the underlying patho...
Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial [0.03%]
二型严重心肾综合征替代疗法的随机对照试验
Maxime Schleef,Florence Sens,Laurent Magaud et al.
Maxime Schleef et al.
Background: Type 2 cardiorenal syndrome (CRS), characterized by chronic heart failure (HF) leading to chronic kidney disease (CKD), is associated with high morbidity and mortality. In patients with refractory congestive H...